Patria Latin American Opportunity Acquisition (PLAO) 10-K 30 Mar 23 2022 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2022	Mar. 28, 2023	Jun. 30, 2022
Document Information Line Items
Entity Registrant Name	PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP.
Trading Symbol	PLAO
Document Type	10-K
Current Fiscal Year End Date	--12-31
Entity Public Float			$ 0
Amendment Flag	false
Entity Central Index Key	0001849737
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Document Annual Report	true
Document Transition Report	false
Entity File Number	001-41321
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	18 Forum Lane
Entity Address, Address Line Two	3rd floor, Camana Bay, PO Box 757
Entity Address, City or Town	Grand Cayman
Entity Address, Country	KY
Entity Address, Postal Zip Code	KY1-9006
City Area Code	1 345
Local Phone Number	640 4900
Title of 12(b) Security	Class A ordinary shares, included as part of the units
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Auditor Firm ID	243
Auditor Name	BDO USA, LLP
Auditor Location	New York, NY
Class A Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		23,000,000
Class B Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		5,750,000

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
ASSETS
Cash	$ 707,749	$ 440
Prepaid expenses	307,756
Marketable securities held in Trust Account	240,311,986
Total current assets	241,327,491	440
Deferred offering costs		638,729
Total Assets	241,327,491	639,169
Current liabilities:
Due to related party	3,144	437,508
Deferred underwriting fees payable	8,050,000
Derivative warrant liabilities	2,340,000
Accrued expenses	68,627	226,529
Total current liabilities	10,461,771	664,037
Total liabilities	10,461,771	664,037
Commitments and Contingencies (Note 5)
Class A ordinary shares subject to possible redemption, 23,000,000 and 0 shares at redemption value	240,311,986
Shareholders’ deficit
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; none issued or outstanding
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding	575	575
Additional paid-in capital		24,425
Accumulated deficit	(9,446,841)	(49,868)
Total shareholders’ deficit	(9,446,266)	(24,868)
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit	$ 241,327,491	$ 639,169

Balance Sheets (Parentheticals)

Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2022	Dec. 31, 2021
Preference shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares authorized	1,000,000	1,000,000
Preference shares, shares issued
Preference shares, shares outstanding
Class A Ordinary Shares
Subject to possible redemption, Shares	23,000,000	0
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued
Common stock, shares outstanding
Class B Ordinary Shares
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	5,750,000	5,750,000
Common stock, shares outstanding	5,750,000	5,750,000

Statements of Operations

Statements of Operations - USD ($)	10 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022
Formation costs	$ 49,308
General and administrative expenses	560	901,733
Loss from operations	(49,868)	(901,733)
Change in fair value of derivative warrant liabilities		7,060,500
Realized gain on investments held in Trust Account		3,411,986
Transaction costs allocation to derivative warrant liabilities		(314,508)
Net income (loss)	$ (49,868)	$ 9,256,245
Class A Ordinary Shares
Weighted average shares outstanding, basic (in Shares)		18,463,014
Basic net income (loss) per share (in Dollars per share)	$ 0	$ 0.74
Class B Ordinary Shares
Weighted average shares outstanding, basic (in Shares)	5,000,000	5,602,055
Basic net income (loss) per share (in Dollars per share)	$ (0.01)	$ (0.78)

Statements of Operations (Paren

Statements of Operations (Parentheticals) - $ / shares	10 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022
Class A Ordinary Shares
Weighted average shares outstanding, diluted		18,463,014
Diluted net income (loss) per share	$ 0	$ 0.74
Class B Ordinary Shares
Weighted average shares outstanding, diluted	5,000,000	5,602,055
Diluted net income (loss) per share	$ (0.01)	$ (0.78)

Statements of Changes in Ordina

Statements of Changes in Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit - USD ($)	Class A Ordinary Shares Subject to Possible Redemption Class A	Class B Ordinary Shares Class B	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Feb. 24, 2021
Balance (in Shares) at Feb. 24, 2021
Insurance of ordinary shares to Sponsor		$ 575	24,425		25,000
Insurance of ordinary shares to Sponsor (in Shares)		5,750,000
Net income (loss)				(49,868)	(49,868)
Balance at Dec. 31, 2021		$ 575	24,425	(49,868)	(24,868)
Balance (in Shares) at Dec. 31, 2021		5,750,000
Proceeds from the sale of Class A Units	$ 230,000,000
Proceeds from the sale of Class A Units (in Shares)	23,000,000
Paid underwriters fees	$ (4,600,000)
Deferred underwriting fees payable	(8,050,000)
Fair value of Public Warrants	(4,151,500)
Other offering costs	(815,157)
Excess cash received over fair value of Private Placement Warrants			9,251,000		9,251,000
Accretion of Class A ordinary shares in redemption value	27,928,643		(9,275,425)	(18,653,218)	(27,928,643)
Net income (loss)				9,256,245	9,256,245
Balance at Dec. 31, 2022	$ 240,311,986	$ 575		$ (9,446,841)	$ (9,446,266)
Balance (in Shares) at Dec. 31, 2022	23,000,000	5,750,000

Statements of Cash Flows

Statements of Cash Flows - USD ($)	10 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022
Cash Flows from Operating Activities
Net income (loss)	$ (49,868)	$ 9,256,245
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Realized gain on investments held in Trust Account		(3,411,986)
Transaction costs allocation to derivative warrant liabilities		314,508
Formation and operating expenses funded by note payable through Sponsor	2,527
Change in fair value of derivative warrant liabilities		(7,060.5)
Formation and operating expenses paid in exchange for Founder Shares	19,308
Changes in operating assets and liabilities:
Prepaid expenses		(307,756)
Accrued expenses	28,473	53,239
Net cash (used in) provided by operating activities	440	(1,156,250)
Cash Flows from Investing Activities
Proceeds from redemption of marketable securities held in Trust Account		715,209,000
Purchase of marketable securities held in Trust Account		(715,209,000)
Investment of cash into Trust Account		(236,900,000)
Net cash used in investing activities		(236,900,000)
Cash Flows from Financing Activities
Repayment of note payable		(437,507)
Repayment of amount due to related party		(147,190)
Proceeds from sale of Class A ordinary shares subject to possible redemption, gross		230,000,000
Proceeds from sale of Private Placement Warrants		14,500,000
Offering costs paid		(5,151,744)
Net cash provided by financing activities		238,763,559
Net increase in cash	440	707,309
Cash — beginning of period		440
Cash — end of period	440	707,749
Supplemental disclosure of noncash investing and financing activities:
Issuance of Class A ordinary shares subject to possible redemption		212,383,343
Immediate accretion of Class A ordinary shares to redemption value		24,516,657
Subsequent accretion of Class A ordinary shares to redemption value		3,411,986
Offering and formation costs paid for by a related party		150,334,000,000
Offering costs included in accrued expenses	198,056	211,141
Offering costs paid through prepaid legal expense funded by sponsor	5,692
Deferred underwriting fees payable		$ 8,050,000

Description of Organization, Bu

Description of Organization, Business Operations, Liquidity and Going Concern Considerations	12 Months Ended
	Dec. 31, 2022
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Abstract]
Description of Organization, Business Operations, Liquidity and Going Concern Considerations	Note 1 — Description of Organization, Business Operations, Liquidity and Going Concern Considerations Patria Latin American Opportunity Acquisition Corp. (the “Company”) is a blank check company incorporated in Cayman Islands on February 25, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, ordinary shares purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of December 31, 2022, the Company had not commenced any operations. All activities for the period from February 25, 2021 (inception), through December 31, 2022, relates to the Company’s formation, and the initial public offering (“IPO”) described below, and post-IPO expenses. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of realized and unrealized gains on investments from the proceeds derived from the IPO. On March 14, 2022, the Company consummated its IPO of 23,000,000 units (the “Units”), including the issuance of 3,000,000 Units as a result of the underwriter’s exercise in full of its over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-half of one redeemable warrant of the Company (each whole warrant, a “Public Warrant”), with each Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000. The Company’s sponsor is Patria SPAC LLC, a Cayman Islands exempted limited partnership (the “Sponsor”). Simultaneously with the closing of the IPO and pursuant to the private placement warrants purchase agreement, the Company completed the private sale of 14,500,000 warrants (the “Private Placement Warrants” and together with the Public Warrants, the “Warrants”) to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $14,500,000. Transaction costs amounted to $13,779,665, including $8,050,000 in deferred underwriting fees payable, $4,600,000 in underwriting fees paid and $1,129,665 in other offering costs, of which $314,508 were expensed and $13,456,157 charged to temporary equity. Following the closing of the IPO on March 14, 2022, an amount of $236,900,000 ($10.30 per Unit) of the proceeds from the IPO and the sale of the Private Placement Warrants, comprised of $225,400,000 of the proceeds from the IPO (which is net of $4,600,000 of the underwriter’s fees) and $11,500,000 of the proceeds of the sale of Private Placement Warrants, was placed in a U.S.-based trust account (the “Trust Account”) at J.P. Morgan Chase Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee. The funds in the Trust Account were invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to earnings on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account until the earliest of: (i) the completion of the Initial Business Combination; (ii) the redemption of the Class A Ordinary Shares included in the Units (the “Public Shares”) if the Company is unable to complete the Initial Business Combination by 15 months after the closing of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus); or (iii) the redemption of the Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with the Initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated the Initial Business Combination by 15 months after the closing of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus) or (B) with respect to any other material provisions relating to shareholders’ rights or pre-Initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commission held in Trust and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company only intends to complete a Business Combination if the post-business combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Upon the closing of the IPO, management has agreed that an amount equal to at least $10.30 per Unit sold in the IPO, including the proceeds from the sale of the Private Placement Warrants, was held in a Trust Account located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company provides the holders (the “Public Shareholders”) of the Company’s issued and outstanding Class A Ordinary Shares, par value $0.0001 per share, sold in the IPO (the “Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Public Shares for a pro rata portion of the amount then held in the Trust Account. The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. If the Company seeks shareholder approval, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Articles of Association (the “Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below) and any Public Shares purchased during or after the IPO in favor of a Business Combination. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The holders of the Founder Shares (the “initial shareholders”) have agreed not to propose an amendment to the Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination by 15 months after the closing of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus) of the IPO (the “Combination Period”) and the Company’s shareholders have not amended the Articles of Association to extend such Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman law to provide for claims of creditors and the requirements of other applicable law. The initial shareholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares after the IPO, they will be entitled to liquidating distributions from the Trust if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.30. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the Trust Account to below (i) $10.30 per unit or (ii) the lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of interest which may be withdrawn to pay taxes, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Going Concern Consideration As of December 31, 2022, the Company had a working capital of $230,865,720. Of the net proceeds from the IPO and associated sale of Private Placement Warrants, $236,900,000 of cash was placed in the Trust Account. The working capital surplus includes the amount of restricted marketable securities held in the Trust Account, deferred underwriting fees payable and derivative warrant liabilities, all of which have been classified as current at December 31, 2022 as a result of the Company being less than 12 months away from consuming the assets held in the Trust Account to either consummate a business combination or to liquidate. Working capital would be $943,734 if the line items described above were not included in the working capital calculation. Cash of $707,749 was held outside of the Trust Account and is available for the Company’s working capital purposes of which $707,749 was remaining as of December 31, 2022. The Company anticipates that the cash held outside of the Trust Account as of December 31, 2022 will not be sufficient to allow the Company to operate for at least the next 12 months from the issuance of the financial statements, assuming that a Business Combination is not consummated during that time. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable and accrued liabilities, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. Management plans to address this uncertainty through the Business Combination as discussed above. In addition, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required under the Working Capital Loans. There is no assurance that the Company’s plans to consummate the Business Combination will be successful or successful within the Combination Period or that the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors will loan the Company funds as may be required under the Working Capital Loans. The financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty or its inability to continue as a going concern. The credit and financial markets have experienced extreme volatility and disruptions due to the current conflict between Ukraine and Russia. The conflict is expected to have further global economic consequences, including but not limited to the possibility of severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability. In addition, the United States and other countries have imposed sanctions on Russia, which increases the risk that Russia, as a retaliatory action, may launch cyberattacks against the United States, its government, infrastructure and businesses. Any of the foregoing consequences, including those we cannot yet predict, may cause our business, financial condition, results of operations and the price of our ordinary shares to be adversely affected.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 — Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and 2021. Investments Held in Trust Account The assets held in the Trust Account were held in U.S. government treasury obligations with maturities of 185 days or less, which were invested in U.S. Treasury securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Earnings on these securities is included in realized gain on investments held in Trust Account in the accompanying statements of operations. Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Accounting Standards Codification (“ASC”) 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 – Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets of liabilities, that are observable, or (iv) inputs that are derived principally from or corroborated by market data through correlation or other means. Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement. Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of ASC 260, “Earnings Per Share.” Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary share outstanding during the period. The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. For the year ended December 31, 2022, the Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placements to purchase Class A Ordinary Shares in the calculation of diluted income (loss) per share, since their inclusion is contingent on a future event. For the period from February 25, 2021 (inception) through December 31, 2021, their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the periods presented. A reconciliation of the net income (loss) per share is below: For the Year Ended For the Period Net income (loss) $ 9,256,245 $ (49,868 ) Less: Accretion of temporary equity in excess of fair value (27,928,643 ) — Net loss including accretion of temporary equity in excess of fair value $ (18,672,398 ) $ (49,868 ) The Company’s statements of operations include a presentation of net income (loss) per share for shares of ordinary shares subject to possible redemption in a manner similar to the two-class method of earnings per share. With respect to the accretion of the Class A Ordinary Shares subject to possible redemption and consistent with ASC 480, “Distinguishing Liabilities from Equity,” in accordance with ASC 480-10-S99-3A, the Company has treated the accretion in excess of fair value in the same manner as a dividend, to the extent the redemption value exceeds the fair value, in the calculation of the net loss per ordinary share. For the Year Ended For the Period Class A Class B Class B Basic and diluted net income (loss) per share Numerator Allocation net loss including accretion of temporary equity in excess of fair value $ (14,325,610 ) $ (4,346,788 ) $ (49,868 ) Deemed dividend for accretion of temporary equity in excess of fair value 27,928,643 - - Allocation of net income (loss) and deemed dividend $ 13,603,033 $ (4,346,788 ) $ (49,868 ) Denominator Weighted average shares outstanding, basic and diluted 18,463,014 5,602,055 5,000,000 Basic and diluted net income (loss) per share $ 0.74 $ (0.78 ) $ (0.01 ) Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC 480. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A Ordinary Shares feature contains certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A Ordinary Shares subject to possible redemption are classified as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets. Accordingly, as of December 31, 2022, 23,000,000 shares of Class A Ordinary Shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. The Class A Ordinary Shares subject to possible redemption are subject to the subsequent measurement guidance in ASC 480-10-S99. Under such guidance, the Company must subsequently measure the shares to their redemption amount because, as a result of the allocation of net proceeds to transaction costs, the initial carrying amount of the ordinary shares is less than $10.00 per share. In accordance with the guidance, the Company has elected to measure the ordinary shares subject to possible redemption to their redemption amount (i.e., $10.30 per share) immediately as if the end of the first reporting period after the IPO, March 14, 2022, was the redemption date. Such changes are reflected in additional paid-in capital, or in the absence of additional paid-in capital, in accumulated deficit. For the year ended December 31, 2022, the Company recorded an accretion of $27,928,643 of which $9,275,425 was recorded in additional paid-in capital and $18,653,218 was recorded in accumulated deficit. At December 31, 2022, 23,000,000 ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. Gross proceeds $ 230,000,000 Less: Class A Ordinary Shares issuance costs (13,465,157 ) Fair value of Public Warrants at issuance (4,151,500 ) Plus: Remeasurement of carrying value to redemption value 27,928,643 Class A Ordinary Shares subject to possible redemption at December 31, 2022 $ 240,311,986 Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net- cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. Derivative Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The warrants issued in connection with the Initial Public Offering are liability classified and the fair value of warrants were initially measured at fair value using a Monte Carlo simulation model for the Public Warrants and Private Placement Warrants. The Class A Ordinary Shares and warrants comprising the units began separate trading on the 52nd day following the date of the IPO. No fractional warrants issued upon separation of the units and only whole warrants will trade. Accordingly, unless a multiple of two units is purchased, the number of warrants issuable to you upon separation of the units will be rounded down to the nearest whole number of warrants. Additionally, the units will automatically separate into their component parts and will not be traded after completion of the Initial Business Combination. Share-based Compensation The Company accounts for Founder Shares issued to its independent directors in accordance with SEC Staff Accounting Bulletin 5T and ASC 718, “Compensation-Stock Compensation.” The fair value of the Founder Shares issued in this arrangement was determined using the implied stock price as of the date of Initial Public Offering of the Company’s Class A ordinary shares and the probability of the success of the Business Combination. Offering Costs Offering costs consist of legal, accounting, underwriting and other costs incurred through the balance sheet date that are directly related to the IPO. Upon the completion of the IPO, the offering costs were allocated using the relative fair values of the Company’s Class A Ordinary Shares and its Public Warrants and Private Placement Warrants. The costs allocated to warrants were recognized in other expenses and those related to the Company’s Class A Ordinary Shares were charged against the carrying value of Class A Ordinary Shares. The Company complies with the requirements of the ASC 340-10-S99-1, “Other Assets and Deferred Costs.” Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2022 and 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. U.S. taxation could be imposed if the Company is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a U.S. trade or business at this time. Additionally, given the nature of the investment income generated from the funds held in the trust account, it is not subject to tax withholdings in the U.S. Moreover, the Company determined that no income tax liability would arise from any other jurisdictions outside of the Cayman Islands. Consequently, income taxes are not reflected in the Company’s financial statements. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020- 06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. As a result of ASU 2020 – 06, more convertible debt instruments will be accounted for as a single liability measured at its amortized cost and more convertible preferred shares will be accounted for as a single equity instrument measured at its historical cost, as long as no features require bifurcation and recognition as derivatives. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is evaluating the impact of ASU 2020-06 on its financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying financial statements.

Initial Public Offering

Initial Public Offering	12 Months Ended
	Dec. 31, 2022
Initial Public Offering [Abstract]
Initial Public Offering	Note 3 – Initial Public Offering Pursuant to the IPO, the Company sold 23,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A Ordinary Share and one-half of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A Ordinary Shares at an exercise price of $11.50 per whole share. The Company had granted the Underwriters in the IPO (the “Underwriters”) a 45-day option to purchase up to 3,000,000 additional Units to cover over-allotments, which was exercised in full on the IPO date.

Private Placement Warrants

Private Placement Warrants	12 Months Ended
	Dec. 31, 2022
Private Placement Warrants [Abstract]
Private Placement Warrants	Note 4 – Private Placement Warrants Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 14,500,000 of Private Placement Warrants, including the overallotment option, at a price of $1.00 per Private Placement Warrant ($14,500,000 in the aggregate). Each Private Placement Warrant is exercisable to purchase one share of Class A Ordinary Shares at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. Upon the purchase of the Private Placement Warrants by the Sponsor, the Company recorded the excess proceeds received over the fair value of the Private Placement Warrants as additional paid-in capital amounting to $9,251,000.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 – Related Party Transactions Founder Shares On March 3, 2021, one of our officers paid $25,000, to cover certain of our offering costs, in exchange for an aggregate of 7,187,500 Class B ordinary shares (the “Founder Shares”), which were temporarily issued to such officer until such shares were transferred to our sponsor in April 2021. Our Sponsor was formed on March 9, 2021. In February 2022, our Sponsor forfeited 1,437,500 Founder Shares for no consideration, remaining with 5,750,000 Founder Shares. Prior to the IPO, on March 9, 2022, our Sponsor transferred 30,000 of our Founder Shares to each of our three independent directors. These 90,000 shares were not subject to forfeiture. The allocation of the Founder Shares to the directors is in the scope of ASC 718. Under ASC 718, share-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Company used the Monte Carlo model to estimate the fair value associated with the Founder Shares granted. The fair value of the 90,000 shares granted to the Company’s directors in March 2022 was $662,245 or $7.36 per share. The Founder Shares were granted subject to a performance condition, the occurrence of an Initial Business Combination. Compensation expense related to the Founder Shares is recognized only when the performance condition is probable of occurrence under ASC 718. The Company determined the performance conditions are not considered probable, and, therefore, no share-based compensation expense was recognized for period ended December 31, 2022 and 2021. As of December 31, 2022, the unrecognized stock compensation expense was $662,245. On March 14, 2022, the underwriters fully exercised the over-allotment option; thus, the 750,000 Founder Shares are no longer subject to forfeiture. The Sponsor has agreed not to transfer, assign or sell any of their founder shares and any Class A Ordinary Shares issued upon conversion thereof until the earlier to occur of (A) one year after the completion of our initial business combination; or (B) subsequent to our initial business combination, (x) if the last reported sale price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date following the completion of our initial business combination on which we complete a liquidation, merger, amalgamation, stock exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property. The Founder Shares will automatically convert into Class A Ordinary Shares concurrently with or immediately following the consummation of the Company’s Initial Business Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A Ordinary Shares or equity-linked securities are issued or deemed issued in connection with the Company’s Initial Business Combination, the number of Class A Ordinary Shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A Ordinary Shares outstanding after such conversion (after giving effect to any redemptions of Class A Ordinary Shares by Public Shareholders), including the total number of Class A Ordinary Shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the Initial Business Combination, excluding any Class A Ordinary Shares or equity-linked securities exercisable for or convertible into Class A Ordinary Shares issued, or to be issued, to any seller in the Initial Business Combination and any Private Placement Warrants issued to the Sponsor, or the Company’s officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. Promissory Note – Related Party On March 3, 2021, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $250,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) December 31, 2022, and (ii) the completion of the IPO. On January 31, 2022, the Company amended the unsecured Promissory Note to provide an additional borrowing of $250,000, for a total borrowing capacity of $500,000. Promissory note balance as of December 31, 2021 was $437,508 which was fully paid upon the Company’s consummation of its initial public offering. There is no outstanding balance on the promissory note as of December 31, 2022. Due to Related Party As of December 31, 2022, the Company had an outstanding balance of $3,144 due to the Sponsor related to expenses paid by the Sponsor on behalf of the Company. This amount is due on demand. During the year ended December 31, 2022, the Company had borrowed $150,334 from the Sponsor, all of which was repaid except the outstanding balance of $3,144. Administrative Services Agreement Following our IPO, the Company pays the Sponsor or an affiliate a monthly fee of $10,000 for office space, utilities, secretarial and administrative services. For the year ended December 31, 2022, we incurred and paid $95,484 in administrative support fees. For the period from February 25, 2021 (inception) through December 31, 2021 we did not incur or pay any fees. Working Capital Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $2,000,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2022 and 2021, the Company had no borrowings under the Working Capital Loans.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6 – Commitments and Contingencies Registration Rights The holders of Founder Shares and Private Placement Warrants, including any that may be issued upon conversion of Working Capital Loans, if any (and any Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants, including any that may be issued upon conversion of the Working Capital Loans), will be entitled to registration rights pursuant to a registration rights agreement entered into prior to the consummation of the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company is not required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriter a 45-day option from the date of the IPO to purchase up to an additional 3,000,000 Units to cover over-allotments. The underwriter fully exercised its over-allotment option concurrently with the close of the IPO. The underwriter was entitled to a cash underwriting discount of $0.20 per Unit (or $4,600,000) of the gross proceeds of the IPO. Additionally, the underwriter is entitled to a deferred underwriting commission of $0.35 per Unit (or $8,050,000) of the gross proceeds of the IPO upon the completion of the Company’s Initial Business Combination. The deferred underwriting commissions will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement.

Derivative Warrant Liabilities

Derivative Warrant Liabilities	12 Months Ended
	Dec. 31, 2022
Derivative Warrant Liabilities [Abstract]
Derivative Warrant Liabilities	Note 7 – Derivative Warrant Liabilities The Company accounted for the 26,000,000 Warrants issued in connection with the IPO (the 11,500,000 of Public Warrants and the 14,500,000 of Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the Warrants do not meet the criteria for equity treatment thereunder, each Warrant much be recorded as a liability. Accordingly, the Company classifies each Warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statements of operations. Each whole Warrant entitles the holder thereof to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. Only whole Warrants are exercisable. The Warrants will become exercisable 30 days after the completion of the Initial Business Combination and will expire five years after the completion of the Initial Business Combination or earlier upon redemption or liquidation. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of an Initial Business Combination provided that the Company has an effective registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or holders are permitted to exercise their Public Warrants on a cashless basis under certain circumstances as a result of (i) the Company’s failure to have an effective registration statement by the 60 th Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00 The Warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of the Initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A Ordinary Share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions) and (z) the volume weighted average trading price of Class A Ordinary Shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the Initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under “ Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00 Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $18.00 The Private Placement Warrants are identical to the Public Warrants, except that, so long as they are held by the Sponsor or its permitted transferees, (i) they will not be redeemable by the Company, (ii) they (including the Class A Ordinary Shares issuable upon exercise of these Warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Initial Business Combination, (iii) they may be exercised by the holders on a cashless basis, (iv) are subject to registration rights and (v) use a different Black-Scholes Warrant Model for purposes of calculating the Black-Scholes Warrant Value (as defined in the warrant agreement). On the exercise of any Warrant, the Warrant exercise price will be paid directly to us and not placed in the Trust Account. Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $18.00: ● in whole and not in part; ● at a price of $0.01 per Warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last reported sale price of Class A Ordinary Shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the Warrants as described above unless an effective registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the Warrants is effective and a current prospectus relating to those Class A Ordinary Shares is available throughout the 30-day redemption period. Any such exercise would not be on a cashless basis and would require the exercising warrant holder to pay the exercise price for each Warrant being exercised. Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00 ● in whole and not in part; ● at a price of $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth in the warrant agreement based on the redemption date and the “redemption fair market value” of Class A Ordinary Shares (as defined below) except as otherwise described in the warrant agreement; ● if, and only if, the closing price of Class A Ordinary Shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and ● if the closing price of the Class A Ordinary Shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. Solely for the purposes of this redemption provision, the “redemption fair market value” of the Company’s Class A Ordinary Shares shall mean the volume weighted average price of the Class A Ordinary Shares for the ten (10) trading days immediately following the date on which notice of redemption is sent to the holders of Warrants. No fractional Class A Ordinary Shares issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class A Ordinary Shares to be issued to the holder.

Shareholder's Deficit

Shareholder's Deficit	12 Months Ended
	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Shareholder's Deficit	Note 8 – Shareholder’s Deficit Preferred Shares – Class A Ordinary Shares Class B Ordinary Shares Holders of the Class A Ordinary Shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares shall have the right to vote on the appointment and removal of the Company’s directors prior to the Initial Business Combination or continuing the Company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents of the Company or to adopt new constitutional documents of the Company, in each case, as a result of the Company approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands).

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2022
Fair Value Measurements [Abstract]
Fair Value Measurements	Note 9 – Fair Value Measurements The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022, including the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. As of December 31, 2021, no financial instruments were measured at fair value on a recurring basis. Level 1 Level 2 Level 3 Total Assets Marketable securities held in Trust Account $ 240,311,986 $ — $ — $ 240,311,986 $ 240,311,986 $ — $ — $ 240,311,986 Liabilities Public Warrants $ 1,035,000 $ — $ — $ 1,035,000 Private Placement Warrants — 1,305,000 — 1,305,000 Total liabilities $ 1,035,000 $ 1,305,000 $ — $ 2,340,000 The Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting date. Changes in the fair value of the Warrants are recorded in the statements of operations each period. Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. During the year ended December 31, 2022, the public and private warrants were transferred out of level 3 into level 1 and level 2, respectively. See the table below to illustrate the transfers out of level 3. Level 3 warrant liabilities at January 1, 2022 $ - Addition at March 14, 2022 due to IPO 9,400,500 Change in fair value of warrant liabilities (7,060,500 ) Transfers from level 3 to level 2 instruments (1,305,000 ) Transfers from level 3 to level 1 instruments (1,035,000 ) Level 3 warrant liabilities at December 31, 2022 $ — The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model. The fair value of Public Warrants issued in connection with the Initial Public Offering was measured based on the listed market price of such warrants, a Level 1 measurement, since May 4, 2022. The fair value of the Private Placement Warrants has subsequently been measured by reference to the trading price of the Public Warrants, which is considered to be a Level 2 fair value measurement. The Company recognized a charge resulting from a decrease in the fair value of warrant liabilities of $7,060,500, which is presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations for the year ended December 31, 2022. The following table provides quantitative information regarding Level 3 fair value measurement inputs for the Public Warrants and Private Placement Warrants at their measurement date: March 14, 2022 March 31, 2022 Exercise Price $ 11.50 $ 11.50 Underlying share price $ 9.82 $ 10.06 Volatility 5.4 % 4.6 % Term to Business Combination (years) 6.05 6.00 Risk-free rate 2.13 % 2.41 % The table below shows the change in fair value of the derivative warrant liabilities as of December 31, 2022: Private Public Total Fair value at January 1, 2022 $ — $ — $ — Fair value at March 14, 2022 due to IPO 5,249,000 4,151,500 9,400,500 Change in fair value 3,944,000 3,116,500 7,060,500 Fair value as of December 31, 2022 $ 1,305,000 $ 1,035,000 $ 2,340,000

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash Equivalents	Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and 2021.
Investments Held in Trust Account	Investments Held in Trust Account The assets held in the Trust Account were held in U.S. government treasury obligations with maturities of 185 days or less, which were invested in U.S. Treasury securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Earnings on these securities is included in realized gain on investments held in Trust Account in the accompanying statements of operations.
Financial Instruments	Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Accounting Standards Codification (“ASC”) 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 – Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets of liabilities, that are observable, or (iv) inputs that are derived principally from or corroborated by market data through correlation or other means. Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of ASC 260, “Earnings Per Share.” Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary share outstanding during the period. The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. For the year ended December 31, 2022, the Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placements to purchase Class A Ordinary Shares in the calculation of diluted income (loss) per share, since their inclusion is contingent on a future event. For the period from February 25, 2021 (inception) through December 31, 2021, their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the periods presented. A reconciliation of the net income (loss) per share is below: For the Year Ended For the Period Net income (loss) $ 9,256,245 $ (49,868 ) Less: Accretion of temporary equity in excess of fair value (27,928,643 ) — Net loss including accretion of temporary equity in excess of fair value $ (18,672,398 ) $ (49,868 ) The Company’s statements of operations include a presentation of net income (loss) per share for shares of ordinary shares subject to possible redemption in a manner similar to the two-class method of earnings per share. With respect to the accretion of the Class A Ordinary Shares subject to possible redemption and consistent with ASC 480, “Distinguishing Liabilities from Equity,” in accordance with ASC 480-10-S99-3A, the Company has treated the accretion in excess of fair value in the same manner as a dividend, to the extent the redemption value exceeds the fair value, in the calculation of the net loss per ordinary share. For the Year Ended For the Period Class A Class B Class B Basic and diluted net income (loss) per share Numerator Allocation net loss including accretion of temporary equity in excess of fair value $ (14,325,610 ) $ (4,346,788 ) $ (49,868 ) Deemed dividend for accretion of temporary equity in excess of fair value 27,928,643 - - Allocation of net income (loss) and deemed dividend $ 13,603,033 $ (4,346,788 ) $ (49,868 ) Denominator Weighted average shares outstanding, basic and diluted 18,463,014 5,602,055 5,000,000 Basic and diluted net income (loss) per share $ 0.74 $ (0.78 ) $ (0.01 )
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC 480. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A Ordinary Shares feature contains certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A Ordinary Shares subject to possible redemption are classified as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets. Accordingly, as of December 31, 2022, 23,000,000 shares of Class A Ordinary Shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. The Class A Ordinary Shares subject to possible redemption are subject to the subsequent measurement guidance in ASC 480-10-S99. Under such guidance, the Company must subsequently measure the shares to their redemption amount because, as a result of the allocation of net proceeds to transaction costs, the initial carrying amount of the ordinary shares is less than $10.00 per share. In accordance with the guidance, the Company has elected to measure the ordinary shares subject to possible redemption to their redemption amount (i.e., $10.30 per share) immediately as if the end of the first reporting period after the IPO, March 14, 2022, was the redemption date. Such changes are reflected in additional paid-in capital, or in the absence of additional paid-in capital, in accumulated deficit. For the year ended December 31, 2022, the Company recorded an accretion of $27,928,643 of which $9,275,425 was recorded in additional paid-in capital and $18,653,218 was recorded in accumulated deficit. At December 31, 2022, 23,000,000 ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. Gross proceeds $ 230,000,000 Less: Class A Ordinary Shares issuance costs (13,465,157 ) Fair value of Public Warrants at issuance (4,151,500 ) Plus: Remeasurement of carrying value to redemption value 27,928,643 Class A Ordinary Shares subject to possible redemption at December 31, 2022 $ 240,311,986
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net- cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The warrants issued in connection with the Initial Public Offering are liability classified and the fair value of warrants were initially measured at fair value using a Monte Carlo simulation model for the Public Warrants and Private Placement Warrants. The Class A Ordinary Shares and warrants comprising the units began separate trading on the 52nd day following the date of the IPO. No fractional warrants issued upon separation of the units and only whole warrants will trade. Accordingly, unless a multiple of two units is purchased, the number of warrants issuable to you upon separation of the units will be rounded down to the nearest whole number of warrants. Additionally, the units will automatically separate into their component parts and will not be traded after completion of the Initial Business Combination.
Share-based Compensation	Share-based Compensation The Company accounts for Founder Shares issued to its independent directors in accordance with SEC Staff Accounting Bulletin 5T and ASC 718, “Compensation-Stock Compensation.” The fair value of the Founder Shares issued in this arrangement was determined using the implied stock price as of the date of Initial Public Offering of the Company’s Class A ordinary shares and the probability of the success of the Business Combination.
Offering Costs	Offering Costs
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2022 and 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. U.S. taxation could be imposed if the Company is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a U.S. trade or business at this time. Additionally, given the nature of the investment income generated from the funds held in the trust account, it is not subject to tax withholdings in the U.S. Moreover, the Company determined that no income tax liability would arise from any other jurisdictions outside of the Cayman Islands. Consequently, income taxes are not reflected in the Company’s financial statements.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020- 06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. As a result of ASU 2020 – 06, more convertible debt instruments will be accounted for as a single liability measured at its amortized cost and more convertible preferred shares will be accounted for as a single equity instrument measured at its historical cost, as long as no features require bifurcation and recognition as derivatives. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is evaluating the impact of ASU 2020-06 on its financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Schedule of reconciliation of the income (loss) per share	For the Year Ended For the Period Net income (loss) $ 9,256,245 $ (49,868 ) Less: Accretion of temporary equity in excess of fair value (27,928,643 ) — Net loss including accretion of temporary equity in excess of fair value $ (18,672,398 ) $ (49,868 ) For the Year Ended For the Period Class A Class B Class B Basic and diluted net income (loss) per share Numerator Allocation net loss including accretion of temporary equity in excess of fair value $ (14,325,610 ) $ (4,346,788 ) $ (49,868 ) Deemed dividend for accretion of temporary equity in excess of fair value 27,928,643 - - Allocation of net income (loss) and deemed dividend $ 13,603,033 $ (4,346,788 ) $ (49,868 ) Denominator Weighted average shares outstanding, basic and diluted 18,463,014 5,602,055 5,000,000 Basic and diluted net income (loss) per share $ 0.74 $ (0.78 ) $ (0.01 )
Schedule of ordinary shares subject to possible redemption	Gross proceeds $ 230,000,000 Less: Class A Ordinary Shares issuance costs (13,465,157 ) Fair value of Public Warrants at issuance (4,151,500 ) Plus: Remeasurement of carrying value to redemption value 27,928,643 Class A Ordinary Shares subject to possible redemption at December 31, 2022 $ 240,311,986

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of company’s assets and liabilities are measured at fair value on a recurring basis	Level 1 Level 2 Level 3 Total Assets Marketable securities held in Trust Account $ 240,311,986 $ — $ — $ 240,311,986 $ 240,311,986 $ — $ — $ 240,311,986 Liabilities Public Warrants $ 1,035,000 $ — $ — $ 1,035,000 Private Placement Warrants — 1,305,000 — 1,305,000 Total liabilities $ 1,035,000 $ 1,305,000 $ — $ 2,340,000
Schedule of public and private warrants were transferred out of level 3 into level 1 and level 2	Level 3 warrant liabilities at January 1, 2022 $ - Addition at March 14, 2022 due to IPO 9,400,500 Change in fair value of warrant liabilities (7,060,500 ) Transfers from level 3 to level 2 instruments (1,305,000 ) Transfers from level 3 to level 1 instruments (1,035,000 ) Level 3 warrant liabilities at December 31, 2022 $ —
Schedule of quantitative information regarding Level 3 fair value measurement inputs for the public warrants and private placement warrants	March 14, 2022 March 31, 2022 Exercise Price $ 11.50 $ 11.50 Underlying share price $ 9.82 $ 10.06 Volatility 5.4 % 4.6 % Term to Business Combination (years) 6.05 6.00 Risk-free rate 2.13 % 2.41 %
Schedule of change in fair value of derivative warrant liabilities	Private Public Total Fair value at January 1, 2022 $ — $ — $ — Fair value at March 14, 2022 due to IPO 5,249,000 4,151,500 9,400,500 Change in fair value 3,944,000 3,116,500 7,060,500 Fair value as of December 31, 2022 $ 1,305,000 $ 1,035,000 $ 2,340,000

Description of Organization, _2

Description of Organization, Business Operations, Liquidity and Going Concern Considerations (Details) - USD ($)		12 Months Ended
	Mar. 14, 2022	Dec. 31, 2022	Dec. 31, 2021
Description of Organization, Business Operations, Liquidity and Going Concern Considerations (Details) [Line Items]
Price, per share (in Dollars per share)		$ 1
Price, per unit (in Dollars per share)		$ 10
Transaction costs		$ 13,779,665
Deferred underwriting fees		8,050,000
Underwriting commissions		4,600,000
Other offering costs		1,129,665
Other cost expensed		314,508
Charged to temporary equity		13,456,157
Private placement warrants		$ 1,305,000
Trust account description		Except with respect to earnings on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account until the earliest of: (i) the completion of the Initial Business Combination; (ii) the redemption of the Class A Ordinary Shares included in the Units (the “Public Shares”) if the Company is unable to complete the Initial Business Combination by 15 months after the closing of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus); or (iii) the redemption of the Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with the Initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated the Initial Business Combination by 15 months after the closing of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus) or (B) with respect to any other material provisions relating to shareholders’ rights or pre-Initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses.
Fair market value percentage		80%
Per unit sold (in Dollars per share)		$ 10.3
Aggregate public share percentage		15%
Public shares redeem percentage		100%
Interest to pay dissolution expenses		$ 100,000
Per share value (in Dollars per share)		$ 10.3
Trust account per unit (in Dollars per share)		$ 10.3
Working capital		$ 943,734
Net proceeds		236,900,000
Cash held in trust account		$ 707,749
IPO [Member]
Description of Organization, Business Operations, Liquidity and Going Concern Considerations (Details) [Line Items]
Additional units (in Shares)	23,000,000	23,000,000
Price, per share (in Dollars per share)	$ 10.3	$ 10
Deferred underwriting fees	$ 4,600,000
Private placement warrants	236,900,000
IPO amount	$ 225,400,000
Working capital		$ 230,865,720
Over-Allotment Option [Member]
Description of Organization, Business Operations, Liquidity and Going Concern Considerations (Details) [Line Items]
Additional units (in Shares)	3,000,000	3,000,000
Private Placement [Member]
Description of Organization, Business Operations, Liquidity and Going Concern Considerations (Details) [Line Items]
Price, per share (in Dollars per share)		$ 1
Gross proceeds		$ 14,500,000
Sale of warrants (in Shares)		14,500,000
Private placement warrants	$ 11,500,000
Trust account [Member]
Description of Organization, Business Operations, Liquidity and Going Concern Considerations (Details) [Line Items]
Working capital		$ 707,749
Class A Ordinary Shares [Member]
Description of Organization, Business Operations, Liquidity and Going Concern Considerations (Details) [Line Items]
Common stock, par value (in Dollars per share)	$ 0.0001
Price, per share (in Dollars per share)	11.5
Price, per unit (in Dollars per share)	$ 10
Gross proceeds	$ 230,000,000
Common stock, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Initial Business Combination [Member]
Description of Organization, Business Operations, Liquidity and Going Concern Considerations (Details) [Line Items]
Business combination acquires percentage		50%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Mar. 14, 2022
Summary of Significant Accounting Policies (Details) [Line Items]
Ordinary share price per share (in Dollars per share)	$ 10
Accretion amount	$ 27,928,643
Additional paid-in capital	9,275,425
Accumulated deficit	$ 18,653,218
Ordinary shares subject to possible redemption (in Shares)	23,000,000
IPO [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Redemption per share (in Dollars per share)	$ 10.3
Class A Ordinary Shares [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Class A ordinary shares subject to possible redemption (in Shares)	23,000,000
Ordinary share price per share (in Dollars per share)		$ 10

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the income (loss) per share - USD ($)	10 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022
Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the income (loss) per share [Line Items]
Net income (loss)	$ (49,868)	$ 9,256,245
Less: Accretion of temporary equity in excess of fair value		(27,928,643)
Net loss including accretion of temporary equity in excess of fair value	$ (49,868)	(18,672,398)
Common Class A [Member]
Numerator
Allocation net loss including accretion of temporary equity in excess of fair value		(14,325,610)
Deemed dividend for accretion of temporary equity in excess of fair value		27,928,643
Allocation of net income (loss) and deemed dividend		$ 13,603,033
Denominator
Weighted average shares outstanding, basic (in Shares)		18,463,014
Basic net income (loss) per share (in Dollars per share)	$ 0	$ 0.74
Common Class B [Member]
Numerator
Allocation net loss including accretion of temporary equity in excess of fair value	$ (49,868)	$ (4,346,788)
Deemed dividend for accretion of temporary equity in excess of fair value
Allocation of net income (loss) and deemed dividend	$ (49,868)	$ (4,346,788)
Denominator
Weighted average shares outstanding, basic (in Shares)	5,000,000	5,602,055
Basic net income (loss) per share (in Dollars per share)	$ (0.01)	$ (0.78)

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the income (loss) per share (Parentheticals) - $ / shares	10 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022
Common Class A [Member]
Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the income (loss) per share (Parentheticals) [Line Items]
Weighted average shares outstanding, diluted		18,463,014
Diluted net income (loss) per share	$ 0	$ 0.74
Common Class B [Member]
Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the income (loss) per share (Parentheticals) [Line Items]
Weighted average shares outstanding, diluted	5,000,000	5,602,055
Diluted net income (loss) per share	$ (0.01)	$ (0.78)

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details) - Schedule of ordinary shares subject to possible redemption	12 Months Ended
	Dec. 31, 2022 USD ($)
Schedule of Ordinary Shares Subject to Possible Redemption [Abstract]
Gross proceeds	$ 230,000,000
Less:
Class A Ordinary Shares issuance costs	(13,465,157)
Fair value of Public Warrants at issuance	(4,151,500)
Plus:
Remeasurement of carrying value to redemption value	27,928,643
Class A Ordinary Shares subject to possible redemption at December 31, 2022	$ 240,311,986

Initial Public Offering (Detail

Initial Public Offering (Details) - $ / shares		12 Months Ended
	Mar. 14, 2022	Dec. 31, 2022
Initial Public Offering (Details) [Line Items]
Purchase price per unit		$ 1
Exercise price per share		$ 11.5
IPO [Member]
Initial Public Offering (Details) [Line Items]
Sold units	23,000,000	23,000,000
Purchase price per unit	$ 10.3	$ 10
Over-Allotment Option [Member]
Initial Public Offering (Details) [Line Items]
Sold units	3,000,000	3,000,000

Private Placement Warrants (Det

Private Placement Warrants (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares
Private Placement Warrants (Details) [Line Items]
Sponsor agreed to purchase | shares	14,500,000
Private Placement [Member]
Private Placement Warrants (Details) [Line Items]
Warrant price per share | $ / shares	$ 1
Aggregate purchase price | $	$ 14,500,000
Per share price | $ / shares	$ 11.5
Additional paid-in capital | $	$ 9,251,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)				1 Months Ended		12 Months Ended
	Mar. 14, 2022	Mar. 09, 2022	Mar. 03, 2021	Feb. 28, 2022	Jan. 31, 2022	Dec. 31, 2022	Mar. 03, 2022	Dec. 31, 2021
Related Party Transactions (Details) [Line Items]
Offering costs			$ 25,000
Aggregate ordinary shares (in Shares)			7,187,500
Founder shares (in Shares)		30,000		1,437,500
Underwriters shares (in Shares)						90,000
Granted shares (in Shares)						90,000
Granted share in amount						$ 662,245
Granted per shares (in Dollars per share)						$ 7.36
Compensation expense						$ 662,245
Exercised shares (in Shares)	750,000
Ordinary per shares (in Dollars per share)						$ 12
Founder share percentage						20%
Principal amount							$ 250,000
Additional borrowing					$ 250,000
Total borrowing capacity					$ 500,000
Promissory note								$ 437,508
Due to related parties						$ 3,144
Sponsor paid expenses						150,334
Outstanding balance						3,144
Office space						10,000
Administrative fees expense						95,484
Working capital loans						$ 2,000,000
Price per share (in Dollars per share)						$ 1
IPO [Member]
Related Party Transactions (Details) [Line Items]
Founder shares (in Shares)				5,750,000
Price per share (in Dollars per share)	$ 10.3					$ 10

Commitments and Contingencies (

Commitments and Contingencies (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares
Commitments and Contingencies (Details) [Line Items]
Underwriting discount per share | $ / shares	$ 0.2
Deferred underwriting commission per share | $ / shares	$ 0.35
Over-Allotment Option [Member]
Commitments and Contingencies (Details) [Line Items]
Additional purchase units | shares	3,000,000
IPO [Member]
Commitments and Contingencies (Details) [Line Items]
Gross proceeds | $	$ 4,600,000
Business Combination [Member] | IPO [Member]
Commitments and Contingencies (Details) [Line Items]
Gross proceeds | $	$ 8,050,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Derivative Warrant Liabilities (Details) [Line Items]
Redemption warrant price per share	$ 10
Business combination, description	The Warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of the Initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A Ordinary Share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions) and (z) the volume weighted average trading price of Class A Ordinary Shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the Initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00” and “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
Price per warrant	$ 0.01
IPO [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Warrants issued (in Shares) | shares	26,000,000
Public Warrants [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Warrants issued (in Shares) | shares	11,500,000
Private Placement Warrants [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Warrants issued (in Shares) | shares	14,500,000
Class A Ordinary Shares [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Warrant price per share	$ 11.5
Redemption warrant price per share	18
Sale price per price	$ 18
Redemption of warrants, description	Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00: Once the Warrants become exercisable, the Company may redeem the outstanding Warrants:  ●in whole and not in part;  ●at a price of $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth in the warrant agreement based on the redemption date and the “redemption fair market value” of Class A Ordinary Shares (as defined below) except as otherwise described in the warrant agreement;  ●if, and only if, the closing price of Class A Ordinary Shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and  ●if the closing price of the Class A Ordinary Shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.

Shareholder's Deficit (Details)

Shareholder's Deficit (Details) - $ / shares		1 Months Ended
	Mar. 09, 2022	Feb. 28, 2022	Dec. 31, 2022	Mar. 14, 2022	Dec. 31, 2021
Shareholder's Deficit (Details) [Line Items]
Preferred shares authorized			1,000,000		1,000,000
Preferred shares par value (in Dollars per share)			$ 0.0001		$ 0.0001
Founder shares	30,000	1,437,500
Class A Ordinary Shares [Member]
Shareholder's Deficit (Details) [Line Items]
Ordinary shares authorized			200,000,000		200,000,000
Ordinary shares par value (in Dollars per share)			$ 0.0001		$ 0.0001
Subject to possible redemption, issued and outstanding			23,000,000		0
Ordinary shares issued
Common Stock, Shares, Issued
Common Class B [Member]
Shareholder's Deficit (Details) [Line Items]
Ordinary shares authorized			20,000,000		20,000,000
Ordinary shares par value (in Dollars per share)			$ 0.0001		$ 0.0001
Over-allotment option				3,000,000	7,187,500
Ordinary shares issued			5,750,000		5,750,000
Common Stock, Shares, Issued			5,750,000		5,750,000
Founder shares		5,750,000
Shares outstanding					7,187,500

Fair Value Measurements (Detail

Fair Value Measurements (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)
Fair Value Disclosures [Abstract]
Warrant liabilities	$ 7,060,500

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of company’s assets and liabilities are measured at fair value on a recurring basis - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Assets
Marketable securities held in Trust Account	$ 240,311,986
Total Assets	240,311,986
Liabilities
Public Warrants	1,035,000
Private Placement Warrants	1,305,000
Total liabilities	2,340,000
Level 1 [Member]
Assets
Marketable securities held in Trust Account	240,311,986
Total Assets	240,311,986
Liabilities
Public Warrants	1,035,000
Private Placement Warrants
Total liabilities	1,035,000
Level 2 [Member]
Assets
Marketable securities held in Trust Account
Total Assets
Liabilities
Public Warrants
Private Placement Warrants	1,305,000
Total liabilities	1,305,000
Level 3 [Member]
Assets
Marketable securities held in Trust Account
Total Assets
Liabilities
Public Warrants
Private Placement Warrants
Total liabilities

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of public and private warrants were transferred out of level 3 into level 1 and level 2 - Private Placement Warrants [Member]	12 Months Ended
	Dec. 31, 2022 USD ($)
Fair Value Measurements (Details) - Schedule of public and private warrants were transferred out of level 3 into level 1 and level 2 [Line Items]
Level 3 warrant liabilities at January 1, 2022
Addition at March 14, 2022 due to IPO	9,400,500
Change in fair value of warrant liabilities	(7,060,500)
Level 3 warrant liabilities at December 31, 2022
Transfers from level 3 to level 2 instruments [Member]
Fair Value Measurements (Details) - Schedule of public and private warrants were transferred out of level 3 into level 1 and level 2 [Line Items]
Transfers from level instruments	(1,305,000)
Transfers from level 3 to level 1 instruments [Member]
Fair Value Measurements (Details) - Schedule of public and private warrants were transferred out of level 3 into level 1 and level 2 [Line Items]
Transfers from level instruments	$ (1,035,000)

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurement inputs for the public warrants and private placement warrants - $ / shares	12 Months Ended
	Mar. 31, 2022	Mar. 14, 2022
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurement Inputs for the Public Warrants and Private Placement Warrants [Abstract]
Exercise Price	$ 11.5	$ 11.5
Underlying share price	$ 10.06	$ 9.82
Volatility	4.60%	5.40%
Term to Business Combination (years)	6 years	6 years 18 days
Risk-free rate	2.41%	2.13%

Fair Value Measurements (Deta_5

Fair Value Measurements (Details) - Schedule of change in fair value of derivative warrant liabilities	12 Months Ended
	Dec. 31, 2022 USD ($)
Fair Value Measurements (Details) - Schedule of change in fair value of derivative warrant liabilities [Line Items]
Fair value at beginning balance
Fair value at March 14, 2022 due to IPO	9,400,500
Change in fair value	7,060,500
Fair value as of ending balance	2,340,000
Public Warrant [Member]
Fair Value Measurements (Details) - Schedule of change in fair value of derivative warrant liabilities [Line Items]
Fair value at beginning balance
Fair value at March 14, 2022 due to IPO	5,249,000
Change in fair value	3,944,000
Fair value as of ending balance	1,305,000
Private Warrant [Member]
Fair Value Measurements (Details) - Schedule of change in fair value of derivative warrant liabilities [Line Items]
Fair value at beginning balance
Fair value at March 14, 2022 due to IPO	4,151,500
Change in fair value	3,116,500
Fair value as of ending balance	$ 1,035,000